Literature DB >> 17141971

Risk factors for neovascular glaucoma after carbon ion radiotherapy of choroidal melanoma using dose-volume histogram analysis.

Naoki Hirasawa1, Hiroshi Tsuji, Hitoshi Ishikawa, Hiroko Koyama-Ito, Tadashi Kamada, Jun-Etsu Mizoe, Yoshiyuki Ito, Shinji Naganawa, Yoshitaka Ohnishi, Hirohiko Tsujii.   

Abstract

PURPOSE: To determine the risk factors for neovascular glaucoma (NVG) after carbon ion radiotherapy (C-ion RT) of choroidal melanoma. METHODS AND MATERIALS: A total of 55 patients with choroidal melanoma were treated between 2001 and 2005 with C-ion RT based on computed tomography treatment planning. All patients had a tumor of large size or one located close to the optic disk. Univariate and multivariate analyses were performed to identify the risk factors of NVG for the following parameters; gender, age, dose-volumes of the iris-ciliary body and the wall of eyeball, and irradiation of the optic disk (ODI).
RESULTS: Neovascular glaucoma occurred in 23 patients and the 3-year cumulative NVG rate was 42.6 +/- 6.8% (standard error), but enucleation from NVG was performed in only three eyes. Multivariate analysis revealed that the significant risk factors for NVG were V50IC (volume irradiated > or =50 GyE to iris-ciliary body) (p = 0.002) and ODI (p = 0.036). The 3-year NVG rate for patients with V50IC > or =0.127 mL and those with V50IC <0.127 mL were 71.4 +/- 8.5% and 11.5 +/- 6.3%, respectively. The corresponding rate for the patients with and without ODI were 62.9 +/- 10.4% and 28.4 +/- 8.0%, respectively.
CONCLUSION: Dose-volume histogram analysis with computed tomography indicated that V50IC and ODI were independent risk factors for NVG. An irradiation system that can reduce the dose to both the anterior segment and the optic disk might be worth adopting to investigate whether or not incidence of NVG can be decreased with it.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17141971     DOI: 10.1016/j.ijrobp.2006.08.080

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  7 in total

1.  Neovascular glaucoma after proton beam therapy of choroidal melanoma: incidence and risk factors.

Authors:  Aline I Riechardt; Daniel Pilger; Dino Cordini; Ira Seibel; Enken Gundlach; Annette Hager; Antonia M Joussen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-07-18       Impact factor: 3.117

2.  Radiation-induced neovascular glaucoma: dose and volume issues.

Authors:  Ah Ram Chang
Journal:  Korean J Ophthalmol       Date:  2010-11-23

Review 3.  Glaucoma after chemical burns and radiation.

Authors:  Cornel Ştefan; Cristina Mihaela Timaru; Daniela Adriana Iliescu; Speranta Schmitzer; Simone De Algerino; Mehdi Batras; Jalaladin Hosseini-Ramhormozi
Journal:  Rom J Ophthalmol       Date:  2016 Oct-Dec

4.  Carbon ion radiotherapy for synchronous choroidal melanoma and lung cancer: A case report.

Authors:  Yan-Shan Zhang; Ting-Chao Hu; Yan-Cheng Ye; Jin-Hua Han; Xiao-Jun Li; Yi-He Zhang; Wei-Zuo Chen; Hong-Yu Chai; Xin Pan; Xin Wang; Yu-Ling Yang
Journal:  World J Clin Cases       Date:  2021-11-26       Impact factor: 1.337

Review 5.  Non-Cancer Effects following Ionizing Irradiation Involving the Eye and Orbit.

Authors:  Juliette Thariat; Arnaud Martel; Alexandre Matet; Olivier Loria; Laurent Kodjikian; Anh-Minh Nguyen; Laurence Rosier; Joël Herault; Sacha Nahon-Estève; Thibaud Mathis
Journal:  Cancers (Basel)       Date:  2022-02-25       Impact factor: 6.639

Review 6.  A review of update clinical results of carbon ion radiotherapy.

Authors:  Hirohiko Tsujii; Tadashi Kamada
Journal:  Jpn J Clin Oncol       Date:  2012-07-13       Impact factor: 3.019

7.  Particle radiotherapy with carbon ion beams.

Authors:  Tatsuya Ohno
Journal:  EPMA J       Date:  2013-03-04       Impact factor: 6.543

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.